Organization named in the records

Ilypsa

Named in 2 passages across 2 documents.

Mentions of Ilypsa in the public Epstein records, with citations.

Ask the documents about Ilypsa Search every mention

--}}

Being named in these documents is not an accusation or evidence of wrongdoing. This page reflects only what the public records literally contain, with citations to the original sources.

Where Ilypsa appears

2 total

ER 257 - CONFIDENTIAL James Niedel, MD, Ph.D., (70), Venture Partner, joined Sprout in May 2002 and helped found New Leaf in 2005. Jim will change his status to Venture Partner in NLV-III with the closing of the new fund. In this role, Jim...

Times Square Tower TEXT-001-HOUSE_OVERSIGHT_024003.txt p.1 View source release ↗

…ntly split to become 2 separate companies), Durata Therapeutics (NLV-II: IPO - July, 2012, NASDAQ: DRTX), and Ilypsa (Sprout IX, exited in sale to Amgen, 6.9x multiple). e Established Private Companies: The New Leaf Team has played the role...

Leadership: NLV_ are leaders in biopharmaceutical investing across all stages and transaction IMAGES-007-HOUSE_OVERSIGHT_024045.txt p.1 View source release ↗

Also named alongside

New York New Leaf NEW LEAF VENTURES III, L.P Harvard Medical School U.S. Securities and Exchange Commission NEW LEAF VENTURE PARTNERS, L.L.C Boston Consulting Group New Leaf Ventures I, L.P All Sprout Funds U.S. Congress Relypsa Amgen

Want context across all of these passages at once?

Ask the documents about Ilypsa